Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06111755
Other study ID # 2000035868
Secondary ID IA-1049344
Status Recruiting
Phase N/A
First received
Last updated
Start date March 26, 2024
Est. completion date February 2025

Study information

Verified date March 2024
Source Yale University
Contact Kathleen A Garrison, PhD
Phone 203-737-6232
Email kathleen.garrison@yale.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project will address research gaps and advance the science of smoking cessation by conducting a randomized controlled trial of an evidence-based, population-level quit smoking text messaging program with or without a smartband.


Description:

Aim 1 of this study is to test within-treatment effects for smoking cessation. The primary outcome will be biochemically (cotinine)-confirmed 7-day point-prevalence abstinence (PPA) at end of treatment (8 weeks). Secondary outcomes will be percent days smoke-free, time to relapse, and rated treatment satisfaction. Aim 2 of this study is to explore sex/gender differences in treatment effects for smoking cessation. Given established sex/gender differences in smoking behavior and cessation,randomization will be stratified by sex/gender and we will measure effects of sex/gender on outcomes. Effect sizes will be estimated for smoking outcomes by sex. Outcomes will be evaluated for those who complete enrollment, defined as those who complete study onboarding.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date February 2025
Est. primary completion date February 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - daily smokers for at least 6 months - report an interest in quitting smoking. Exclusion Criteria: - reporting being currently enrolled in another quit smoking program

Study Design


Related Conditions & MeSH terms


Intervention

Other:
SmokefreeTXT
National Cancer Institute's SmokefreeTXT is a text message quit smoking program available nationally. Users sign up and choose a target quit date that is within 2 weeks of their signup date. Users receive 3-5 text messages per day for up to 2 weeks pre-quit and 6 weeks post-quit. The quit date can be reset as often as needed by the user.
Device:
Smartband
A smartband that will track smoking in real-time and ask the individual to confirm/deny smoking. Participants will be asked to wear the smartband during their waking hours and to charge it overnight.

Locations

Country Name City State
United States National online recruitment New Haven Connecticut

Sponsors (2)

Lead Sponsor Collaborator
Yale University American Lung Association

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants with cotinine confirmed 7-day point-prevalence abstinence (PPA) at end of treatment (8 weeks) 7-day PPA at end of treatment with be confirmed via cotinine testing in saliva 8 weeks
Secondary Change in cigarettes smoked per day Change in average number cigarettes smoked per day by self report baseline, 4 weeks and 8 weeks
Secondary Percent days smoke-free Percentage of smoke-free days by self report up to 8 weeks
Secondary Average number of days to relapse Relapse is defined as 7 consecutive days of smoking after quitting and will be measured using self-report or smartband detection. This will be assessed after their quit date. 2 weeks post quit date
Secondary Treatment satisfaction assessed using the User Burden Scale User burden scale: User burden will be assessed using items on a 5 point Likert scale with scores from 0 (not at all/never) to 4 (extremely/all of the time). Means will be reported for 6 subscales (difficulty of use, physical, time and social, mental and emotional, privacy, financial) and an overall scale range 0 to 80, with higher scores indicating more user burden. up to 8 weeks
Secondary Treatment satisfaction assessed using the System Usability Scale System usability scale: Uses 10 items ranked from 1 (strongly disagree) to 5 (strongly agree) with a total score 0-100 with higher score indicating better system usability. up to 8 weeks
Secondary Treatment satisfaction assessed using the Mobile Application Rating Scale User version This 20-item scale uses 5-point multiple choice ratings and has 6 subscales. Scores are reported as: 1) mean app quality, which is the mean score for the 4 subscales engagement, functionality, aesthetics, information quality; 2) mean of the app subjective quality subscale, and 3) mean of the perceived impact subscale. Higher scores indicate higher app quality, higher app subjective quality, and higher perceived impact. Mean scores range 1-5, with higher scores indicate higher app quality, higher app subjective quality, and higher perceived impact. up to 8 weeks
Secondary Treatment satisfaction assessed using the Acceptability of Intervention Measure Acceptability of Intervention Measure includes three scales for Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM). Each measure includes 4 items rated on a 5-point Likert scale from "completely disagree" to "completely agree" and average subscale responses are reported (out of 5) with higher scores indicating greater acceptability, appropriateness, or feasibility. up to 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT04043728 - Addressing Psychological Risk Factors Underlying Smoking Persistence in COPD Patients: The Fresh Start Study N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT04617444 - The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function N/A
Completed NCT02796391 - Facilitating Smoking Cessation With Reduced Nicotine Cigarettes Phase 2
Completed NCT03397511 - Incorporating Financial Incentives to Increase Smoking Cessation Among Asian Americans Residing in New York City N/A
Not yet recruiting NCT05188287 - A Culturally Tailored Smartphone Application for African American Smokers N/A
Recruiting NCT05264428 - The Effect of Honey on Lessening the Withdrawal Symptoms N/A
Recruiting NCT05846841 - Personalized Tobacco Treatment in Primary Care (MOTIVATE) N/A
Completed NCT04133064 - Assessment of the Pivot Breath Sensor: Single-Arm Cohort Study N/A
Completed NCT03187730 - Integrating Financial Management Counseling and Smoking Cessation Counseling to Reduce Health and Economic Disparities in Low-Income Immigrants Phase 4
Completed NCT03474783 - To Explore the Factors Affecting the Effectiveness of Smoking Cessation N/A
Completed NCT04635358 - Feasibility Study of Smoking Cessation for the Staff of a Hospital Center N/A
Terminated NCT03670264 - BE Smokefree: Behavioral Economics Incentives to Engage Adolescents in Smoking Cessation N/A
Not yet recruiting NCT06307496 - VIDeOS for Smoking Cessation N/A
Completed NCT03206619 - A Health Recommeder System to Tailor Message Preferences in a Smoking Cessation Programme
Completed NCT02905656 - Strategies to Promote Cessation in Smokers Who Are Not Ready To Quit N/A
Completed NCT02997657 - Positive Psychotherapy for Smoking Cessation Enhanced With Text Messaging: A Randomized Controlled Trial N/A
Completed NCT02239770 - Pharmacokinetics of Nicotine Film in Smokers N/A
Completed NCT02562521 - A Smoking Cessation Intervention for Yale Dining Employees Phase 4
Recruiting NCT02422914 - Benefits of Tobacco Free Cigarette N/A